低分子肝素用于心肺复苏对患者存活率及并发症的影响  

Effects of low molecular weight heparin on the survival and complication for patients during cardiopulmonary resuscitation

作　　者：施旖旎[1] 金小岩[1] 

机构地区：[1]中山大学附属第二医院急诊科,广东广州510120

出　　处：《中国医药导报》2009年第32期17-19,共3页China Medical Herald

摘　　要：目的:观察低分子肝素在心肺复苏中使用对患者死亡率及并发症的影响。方法:选择75例心搏骤停患者,在心肺复苏期间,分别给予低分子肝素抗凝(L组)和不给予低分子肝素(C组),观察两组患者的心肺复苏成功率、24h和30d存活率以及患者并发症的发生率。结果:L组患者24h存活率高于C组(P<0.05),18h内心梗再发率低于C组(P<0.05),脑出血和脑功能正常比率高于C组(P<0.05)。结论:低分子肝素用于心肺复苏可能会改善患者的存活率,但也有比较高的并发症发生率。Objective： To study the effects of low molecular weight hcparin on the survival and complications for patients during eardiopulmonary resuscitation. Methods： 75 patients with cardiac arrest undergoing cardiopulmonary resuscitation were enrolled in the study. The patients were treated with low molecular weight heparin （L group） and without low molecular weight heparin （C group）. CPR achievement ratio, 24-hour survival, 30-day survival and complications were assessed. Results： 24-hour survival of the L group was higher than that of the C group （P〈0.05）, myocardial reinfarction in 18-hour of the L group was lower than that of the C group （P〈0.05）, but intraeranial hemorrhage occurred with significantly greater frequency in the L group, although the patients showed better cerebral performance （P〈0.05）. Conclusion： Short-term survival is improved when low molecular weight heparin is used during cardiopulmonary resuscitation, but the complications seems relatively high.

关 键 词：低分子肝素 心肺复苏 存活率 并发症 

分 类 号：R973.2[医药卫生—药品]